- AutorIn
- Alexandra Wolff
- Arne C. Rodloff
- Paul Vielkind
- Toralf Borgmann
- Catalina-Suzana Stingu
- Titel
- Antimicrobial Susceptibility of Clinical Oral Isolates of Actinomyces spp.
- Zitierfähige Url:
- https://nbn-resolving.org/urn:nbn:de:bsz:15-qucosa2-857376
- Quellenangabe
- Microorganisms
Erscheinungsjahr: 2022
Jahrgang: 10
Heft: 1
E-ISSN: 2076-2607
Artikelnummer: 125 - Erstveröffentlichung
- 2022
- Abstract (EN)
- Actinomyces species play an important role in the pathogenesis of oral diseases and infections. Susceptibility testing is not always routinely performed, and one may oversee a shift in resistance patterns. The aim of the study was to analyze the antimicrobial susceptibility of 100 well-identified clinical oral isolates of Actinomyces spp. against eight selected antimicrobial agents using the agar dilution (AD) and E-Test (ET) methods. We observed no to low resistance against penicillin, ampicillin-sulbactam, meropenem, clindamycin, linezolid and tigecycline (0–2% ET, 0% AD) but high levels of resistance to moxifloxacin (93% ET, 87% AD) and daptomycin (83% ET, 95% AD). The essential agreement of the two methods was very good for benzylpenicillin (EA 95%) and meropenem (EA 92%). The ET method was reliable for correctly categorizing susceptibility, in comparison with the reference method agar dilution, except for daptomycin (categorical agreement 87%). Penicillin is still the first-choice antibiotic for therapy of diseases caused by Actinomyces spp.
- Andere Ausgabe
- Link zur Erstveröffentlichung
Link: https://doi.org/10.3390/microorganisms10010125 - Freie Schlagwörter (EN)
- Actinomyces; susceptibility testing; agar dilution; E-Test
- Klassifikation (DDC)
- 570
- Verlag
- MDPI, Basel
- Version / Begutachtungsstatus
- publizierte Version / Verlagsversion
- URN Qucosa
- urn:nbn:de:bsz:15-qucosa2-857376
- Veröffentlichungsdatum Qucosa
- 02.06.2023
- Dokumenttyp
- Artikel
- Sprache des Dokumentes
- Englisch
- Lizenz / Rechtehinweis
CC BY 4.0